TRAB Financials 07/15/2014 18:58:51
TheraBiogen Inc.
Period Ending Feb 29, 2012 Feb 28, 2011 Feb 28, 2010
Total Revenue 951 466 -
Cost of Revenue 782 489 -
Gross Profit 169 (22) -
Operating Expenses
Research and Development - - -
Sales, General and Admin. 15,892 3,675 884
Non-Recurring Items - - -
Other - - -
Operating Income (15,724) (3,697) (884)
Income From Continuing Operations
Add'l Income/Expense Items - 2 -
Earnings Before Interest and Tax (15,723) (3,695) (883)
Interest Expense 434 398 62
Earnings Before Tax (16,157) (4,093) (946)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (16,157) (4,093) (946)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (16,157) (4,093) (946)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (16,157) (4,093) (946)